edomain

1. Zika E (domain III) (DAGA-313) Zika E (domain III) (DAGA-313) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION PRODUCT INFORMATION Product Overview Product Overview C-terminal 6xHis tagged E (domain III) (Zika) (GenBank # ALU33341, aa 593-699) Antigen Description Antigen Description Zika virus is an emerging disease that is spread by Aedes mosquitoes. The virus was first isolated in Central Africa, and has since been spread to South Asia and recently to South America. Zika virus can cause mild fever, rash, myalgia, arthralgia and headaches, with one in four infected individuals being asymptomatic. Due to similar symptoms Zika virus infected individuals can easily be mis-diagnosed as a dengue infection and vice-versa. In addition, Zika virus has been implicated in causing microcephaly through transmission in utero. Nature Nature Recombinant Expression System Expression System HEK293 Purity Purity >90%, based on SDS PAGE Conjugate Conjugate Unconjugated Applications Applications WB standard, antibody ELISA, immunogen, etc Format Format Liquid Concentration Concentration Batch dependent - please inquire should you have specific requirements. Size Size 100 µg Buffer Buffer Each vial contains 100 µg of protein in PBS with 8M Urea. Storage Storage Keep it at 4°C if used within a month. For long term storage, split it into small aliquots and keep at -80oC. Avoid repeated freezing and thawing. The product will be expired one year after receiving if stored properly. BACKGROUND BACKGROUND Keywords Keywords Zika virus; ZIKV; Zika virus E (domain III); ZIKV E (domain III); Zika virus E (domain III); Flaviviridae; Flavivirus 45-1 Ramsey Road, Shirley, NY 11967, USA Email: info@creative-diagnostics.com Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved